TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 84 filers reported holding TG THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,620 | -22.0% | 3,543 | +131.7% | 0.00% | – |
| Q2 2023 | $37,980 | +57.4% | 1,529 | -4.7% | 0.00% | – |
| Q1 2023 | $24,124 | +116.0% | 1,604 | +69.9% | 0.00% | – |
| Q4 2022 | $11,168 | +39.6% | 944 | -29.8% | 0.00% | – |
| Q3 2022 | $8,000 | +60.0% | 1,344 | +9.4% | 0.00% | – |
| Q2 2022 | $5,000 | -50.0% | 1,228 | +7.2% | 0.00% | – |
| Q1 2022 | $10,000 | -50.0% | 1,146 | +1.9% | 0.00% | – |
| Q4 2021 | $20,000 | -73.7% | 1,125 | -51.1% | 0.00% | – |
| Q3 2021 | $76,000 | -14.6% | 2,299 | +0.3% | 0.00% | – |
| Q2 2021 | $89,000 | +74.5% | 2,293 | +116.3% | 0.00% | – |
| Q1 2021 | $51,000 | -13.6% | 1,060 | -7.2% | 0.00% | – |
| Q4 2020 | $59,000 | +118.5% | 1,142 | +13.6% | 0.00% | – |
| Q3 2020 | $27,000 | +170.0% | 1,005 | +0.5% | 0.00% | – |
| Q1 2020 | $10,000 | -9.1% | 1,000 | 0.0% | 0.00% | – |
| Q4 2019 | $11,000 | +175.0% | 1,000 | +66.7% | 0.00% | – |
| Q3 2018 | $4,000 | -50.0% | 600 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | -63.6% | 600 | -62.5% | 0.00% | – |
| Q1 2018 | $22,000 | +450.0% | 1,600 | +166.7% | 0.00% | – |
| Q4 2017 | $4,000 | -50.0% | 600 | 0.0% | 0.00% | – |
| Q3 2017 | $8,000 | +33.3% | 600 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | +200.0% | 600 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -89.5% | 600 | -76.9% | 0.00% | – |
| Q3 2016 | $19,000 | +11.8% | 2,600 | -7.5% | 0.00% | – |
| Q2 2016 | $17,000 | -32.0% | 2,810 | -0.3% | 0.00% | – |
| Q1 2016 | $25,000 | -28.6% | 2,818 | +0.1% | 0.00% | – |
| Q4 2015 | $35,000 | +1650.0% | 2,814 | +1215.0% | 0.00% | – |
| Q3 2015 | $2,000 | -94.4% | 214 | -90.3% | 0.00% | – |
| Q2 2015 | $36,000 | +1700.0% | 2,207 | +1724.0% | 0.00% | – |
| Q1 2015 | $2,000 | 0.0% | 121 | 0.0% | 0.00% | – |
| Q4 2014 | $2,000 | – | 121 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |